Novartis have issued a 'Dear Healthcare Professional' letter announcing the association of daptomycin [Cubicin] with pulmonary eosinophilia.

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1338, 2011-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cephalon has issued a "Dear Healthcare Professional" letter announcing that modafinil [Provigil] is now only indicated

By  

Reactions Weekly, Vol. 1, Iss. 1343, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Novartis Oncology have issued a letter alerting healthcare providers of new safety information, including a boxed warning, for Exjade

By  

Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Jones Pharma Incorporated has issued a `Dear Healthcare Professional' letter advising of changes to the US labelling of Levoxyl [levothyroxine sodium].

By  

Reactions Weekly, Vol. 1, Iss. 1023, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Sanofi-aventis has issued a `Dear Healthcare Professional' letter outlining changes to the Ketek [telithromycin] label

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Eli Lilly has issued a `Dear Healthcare Professional' letter to advise of a new warning on the US Xigris [drotrecogin alfa] label

By  

Reactions Weekly, Vol. 1, Iss. 1044-1045, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite